{"groups":[{"description":"Participants receiving a combination of Elotuzumab (E) Lenalidomide (L) Dexamethasone (d) in a 28 day cycle","id":"FG000","title":"E-Ld Cohort"},{"description":"Participants receiving a combination of Lenalidomide (L) Dexamethasone (d) in a 28 day cycle","id":"FG001","title":"Ld Cohort"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}],"type":"No longer meeting study criteria"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}],"type":"Participant request to discontinue"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}],"type":"Adverse event unrelated to study drug"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"}],"type":"Consent withdrawal"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"374"},{"groupId":"FG001","numSubjects":"374"}],"comment":"Started = randomized","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"371"},{"groupId":"FG001","numSubjects":"371"}],"comment":"Completed = continued to the treatment period","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"}],"type":"NOT COMPLETED"}],"title":"Pre-treatment Period"},{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"117"},{"groupId":"FG001","numSubjects":"145"}],"type":"Disease progression"},{"reasons":[{"groupId":"FG000","numSubjects":"110"},{"groupId":"FG001","numSubjects":"73"}],"type":"Adverse event unrelated to study drug"},{"reasons":[{"groupId":"FG000","numSubjects":"52"},{"groupId":"FG001","numSubjects":"64"}],"type":"Study drug toxicity"},{"reasons":[{"groupId":"FG000","numSubjects":"30"},{"groupId":"FG001","numSubjects":"22"}],"type":"Participant request to discontinue"},{"reasons":[{"groupId":"FG000","numSubjects":"30"},{"groupId":"FG001","numSubjects":"30"}],"type":"Other reasons"},{"reasons":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"7"}],"type":"Consent withdrawal"},{"reasons":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"6"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"4"}],"type":"Poor/Non-compliance"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"}],"type":"Maximum clinical benefit"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"}],"type":"No longer meet study criteria"},{"reasons":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"16"}],"type":"Administrative reasons by Sponsor"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"371"},{"groupId":"FG001","numSubjects":"371"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"371"},{"groupId":"FG001","numSubjects":"371"}],"type":"NOT COMPLETED"}],"title":"Treatment Period"}]}